📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021. (2022)

First Author: Martin J

Attributed to: MRC Centre for Global Infectious Disease Analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.15585/mmwr.mm7124a2

PubMed Identifier: 35709073

Publication URI: http://europepmc.org/abstract/MED/35709073

Type: Journal Article/Review

Volume: 71

Parent Publication: MMWR. Morbidity and mortality weekly report

Issue: 24

ISSN: 0149-2195